Nuwellis Debt to Equity Ratio 2011-2024 | NUWE
Current and historical debt to equity ratio values for Nuwellis (NUWE) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Nuwellis debt/equity for the three months ending December 31, 2024 was 0.00.
| Nuwellis Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-12-31 |
$0.00B |
$0.01B |
0.51 |
| 2024-09-30 |
$0.00B |
$0.00B |
1.12 |
| 2024-06-30 |
$0.01B |
$-0.01B |
-1.91 |
| 2024-03-31 |
$0.01B |
$0.00B |
6.53 |
| 2023-12-31 |
$0.01B |
$0.00B |
2.04 |
| 2023-09-30 |
$0.00B |
$0.01B |
0.46 |
| 2023-06-30 |
$0.00B |
$0.01B |
0.40 |
| 2023-03-31 |
$0.01B |
$0.01B |
0.35 |
| 2022-12-31 |
$0.01B |
$0.01B |
1.00 |
| 2022-09-30 |
$0.00B |
$0.01B |
0.32 |
| 2022-06-30 |
$0.00B |
$0.02B |
0.25 |
| 2022-03-31 |
$0.00B |
$0.02B |
0.20 |
| 2021-12-31 |
$0.00B |
$0.03B |
0.17 |
| 2021-09-30 |
$0.00B |
$0.03B |
0.14 |
| 2021-06-30 |
$0.00B |
$0.03B |
0.14 |
| 2021-03-31 |
$0.00B |
$0.03B |
0.11 |
| 2020-12-31 |
$0.00B |
$0.02B |
0.23 |
| 2020-09-30 |
$0.00B |
$0.02B |
0.17 |
| 2020-06-30 |
$0.00B |
$0.01B |
0.37 |
| 2020-03-31 |
$0.00B |
$0.01B |
0.30 |
| 2019-12-31 |
$0.00B |
$0.00B |
1.82 |
| 2019-09-30 |
$0.00B |
$0.00B |
0.75 |
| 2019-06-30 |
$0.00B |
$0.01B |
0.36 |
| 2019-03-31 |
$0.00B |
$0.01B |
0.23 |
| 2018-12-31 |
$0.00B |
$0.01B |
0.48 |
| 2018-09-30 |
$0.00B |
$0.01B |
0.22 |
| 2018-06-30 |
$0.00B |
$0.01B |
0.24 |
| 2018-03-31 |
$0.00B |
$0.01B |
0.16 |
| 2017-12-31 |
$0.00B |
$0.02B |
0.14 |
| 2017-09-30 |
$0.00B |
$0.01B |
0.34 |
| 2017-06-30 |
$0.00B |
$0.01B |
0.24 |
| 2017-03-31 |
$0.00B |
$0.00B |
1.03 |
| 2016-12-31 |
$0.01B |
$0.00B |
2.33 |
| 2016-09-30 |
$0.00B |
$0.00B |
1.69 |
| 2016-06-30 |
$0.01B |
$0.00B |
2.52 |
| 2016-03-31 |
$0.01B |
$0.01B |
1.34 |
| 2015-12-31 |
$0.01B |
$0.01B |
1.01 |
| 2015-09-30 |
$0.01B |
$0.02B |
0.59 |
| 2015-06-30 |
$0.01B |
$0.03B |
0.42 |
| 2015-03-31 |
$0.01B |
$0.03B |
0.29 |
| 2014-12-31 |
$0.00B |
$0.03B |
0.11 |
| 2014-09-30 |
$0.00B |
$0.04B |
0.08 |
| 2014-06-30 |
$0.00B |
$0.04B |
0.07 |
| 2014-03-31 |
$0.00B |
$0.05B |
0.06 |
| 2013-12-31 |
$0.00B |
$0.05B |
0.07 |
| 2013-09-30 |
$0.00B |
$0.06B |
0.05 |
| 2013-06-30 |
$0.00B |
$0.02B |
0.11 |
| 2013-03-31 |
$0.00B |
$0.01B |
0.20 |
| 2012-12-31 |
$0.00B |
$0.01B |
0.16 |
| 2012-09-30 |
$0.00B |
$0.02B |
0.14 |
| 2012-06-30 |
$0.00B |
$0.00B |
3.51 |
| 2012-03-31 |
$0.00B |
$0.00B |
0.70 |
| 2011-12-31 |
$0.00B |
$0.01B |
0.62 |
| 2011-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2011-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2011-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2010-12-31 |
$0.00B |
$0.01B |
0.07 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED INSTRUMENTS |
$0.005B |
$0.009B |
|
Nuwellis Inc. is a medical device company. It is focused on developing, manufacturing and commercializing the Aquadex SmartFlow(R) System for ultrafiltration therapy. Nuwellis Inc., formerly known as CHF Solutions, is headquartered in Minneapolis, Minn.
|
